Gain a US perspective on the latest technologies and novel biomarkers driving forward translational research and precision medicine
Featuring 40+ presentations, the event brings together over 300 attendees from leading pharma, biotech and academic organisations working in the biomarker industry across multiple therapeutic areas, allowing attendees to gain insights into the latest novel biomarker data and technologies.
The 2022 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
Below are some of the confirmed speakers for 2022’s Biomarkers US: In-Person
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of on-site experiences.